Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Cohort studies show that median survival in cirrhotic patients that present with overt HE is only a few months and they have a 2-times higher risk for death at one year of follow-up, compared with cirrhotic patients without HE.6,7 In Mexican patients with cirrhosis, the prevalence of MHE has been reported at 11.5%.8 According to an October 2018 press release, HE accounts for 10% of all hospital admissions at a tertiary care referral center in Mexico City.9 Definitions and classification 1 HE is defined as a brain dysfunction caused by liver failure and/or portosystemic blood shunting
Patients should not change their dose or treatment schedule without medical guidance
Overall discontinuation rates due to adverse events were low at 5.9% for CagriSema vs 3.5% for placebo
$179 A longevity-focused peptide studied for its effects on cellular aging markers and sleep quality
US$ 26.37
US$ 22.89
US$ 21.30
US$ 29.55
